Figure 6From: Clinical and pathologic factors associated with survival in young adult patients with fibrolamellar hepatocarcinomaSurvival analysis of prognostic factors of patients with FLC. Patients who underwent surgical treatment with positive (n = 5, median survival of 20 ± 5 months) and negative (n = 5, median survival of 65 ± 4 months) surgical borders, p= 0.06.Back to article page